AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Launched by GUO SHIWEI · Oct 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of artificial intelligence (AI) to help detect multiple types of cancer early through a special type of imaging called non-contrast CT scans. The goal is to see how well this AI-assisted method can identify cancers like lung, liver, stomach, colorectal, esophageal, pancreatic, and breast cancer in people who do not have any symptoms. By enrolling 1 million participants during routine health checks, researchers hope to improve early detection, which is crucial for better treatment outcomes and survival rates.

To be eligible for the trial, you should be between the ages of 65 and 74, be willing to provide consent, and have recently undergone a non-contrast CT scan of your chest or abdomen. However, if you have been diagnosed with one of the cancers mentioned within the last five years or have certain medical conditions that would prevent you from undergoing high-resolution imaging, you may not qualify. Participants will receive a CT scan, and if any potential cancer is found, they will be referred to a hospital for further examination and care. This trial aims not only to test the AI technology but also to ensure that individuals receive the necessary follow-up for their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subject is able and willing to provide informed consent and sign an informed consent form.
• • 2. Subject has undergone an abdominal or chest non-contrast CT scan.
• Exclusion Criteria:
• • 1. Subject has been diagnosed with one of the following cancers within the last five years: lung, liver, stomach, colon, esophageal, pancreatic, or breast cancer;
• • 2. Subject has any medical condition that contraindicates high-resolution MRI/CT/Endoscopy;
• • 3. Subject cannot be followed up or is participating in other clinical trials.